pillbase.ru

Vyvgart

Active substance: efgartigimod alfa

efgartigimod alfa

Centralised EU authorisationActive

Marketing holder: Argenx

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 3
  • VYVGART
    INJECTION · EFGARTIGIMOD ALFA 20 mg/mL
    73475-3041
    argenx US
  • VYVGART Hytrulo
    INJECTION, SOLUTION · EFGARTIGIMOD ALFA 180 mg/mL, HYALURONIDASE (HUMAN RECOMBINANT) 2000 U/mL
    73475-3102
    argenx US
  • VYVGART Hytrulo
    INJECTION, SOLUTION · EFGARTIGIMOD ALFA 200 mg/mL, HYALURONIDASE (HUMAN RECOMBINANT) 2000 U/mL
    73475-1221
    argenx US
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12090-f125-7f2a-9fd3-82de2c9383b2;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005849
Registration status
Active
ATC code
L04AA58
Sources
  • product · EMA · EMEA/H/C/005849 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005849 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005849 · Verified 2026-10-09